Published November 2018 | Version v1
Journal article

Association of Interim FDG-PET Imaging During Chemoradiation for Squamous Anal Canal Carcinoma With Recurrence

  • 1. Department of Radiation Oncology, Duke University, Durham, North Carolina (United States)
  • 2. Department of Radiology, Stanford University, Stanford (United States)
  • 3. Duke Cancer Institute, Biostatistics Shared Resource, Duke University, Durham, North Carolina (United States)
  • 4. Department of Radiation Oncology, St. Jude Children's Research Hospital, Memphis (United States)

Description

Imaging parameters from 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) before and after chemoradiation therapy (CRT) for anal canal cancer correlate with clinical outcomes. This prospective, hypothesis-generating pilot study investigates the relationship between interim PET imaging during CRT for anal canal cancer and clinical outcome.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.ijrobp.2018.04.062

Additional details

Identifiers

DOI
10.1016/j.ijrobp.2018.04.062;
PII
S0360301618307405;

Publishing Information

Journal Title
International Journal of Radiation Oncology, Biology and Physics
Journal Volume
102
Journal Issue
4
Journal Page Range
p. 1046-1051
ISSN
0360-3016
CODEN
IOBPD3

Optional Information

Copyright
Copyright (c) 2018 Elsevier Inc. All rights reserved.